Analyst Ratings for Conmed
Portfolio Pulse from Benzinga Insights
Conmed (NYSE:CNMD) has received mostly bullish ratings from analysts in the last quarter, with 5 bullish, 2 somewhat bullish, and 1 indifferent rating. The average price target for the stock is $132.62, which is an 11.6% increase from the previous average of $118.83. The current price of Conmed is $121.6.
July 24, 2023 | 9:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Analysts have given Conmed (NYSE:CNMD) mostly bullish ratings, with an average price target of $132.62, indicating potential upside.
The majority of analysts have given Conmed bullish ratings, indicating a positive outlook for the stock. The average price target is also higher than the current price, suggesting potential for growth.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100